Otolaryngologic Effects of Inhaled Medications Used in Pulmonary Medicine: A Review

Article Sidebar

PDF

Downloads

Download data is not yet available.

Submit your own article

Register as an author to reserve your spot in the next issue of the Medical Research Archives.

Author Registration

Join the Society

The European Society of Medicine is more than a professional association. We are a community. Our members work in countries across the globe, yet are united by a common goal: to promote health and health equity, around the world.

Join Europe’s leading medical society and discover the many advantages of membership, including free article publication.

Membership

Main Article Content

Rachel Butz Crow
School of Medicine, Louisiana State University Health Sciences Center, New Orleans, LA
Jacob Seicshnaydre, MD
Department of Otolaryngology - Head & Neck Surgery, Louisiana State University Health Sciences Center, New Orleans, LA
Juzar Ali, MD, FRCP(C)
Section of Pulmonary/CC/Allergy & Immunology, Louisiana State University Health Sciences Center, New Orleans, LA

Abstract

Aerosolization of medications has proven to be a highly beneficial method of delivery in treating various pulmonary conditions, including obstructive lung disease, cystic fibrosis, bronchiectasis, and respiratory tract infections. There is also evidence showing its usefulness in treating upper airway disorders such as laryngotracheal stenosis and chronic rhinosinusitis. However, inhalation of medications may lead to adverse effects such as dysphonia, cough, local irritation, inflammation and infection. This review explores both the favorable and unfavorable otolaryngologic effects experienced by patients receiving commonly used inhalational therapies and the need for a balanced approach in its use.

Article Details

How to Cite
BUTZ CROW, Rachel; SEICSHNAYDRE, MD, Jacob; ALI, MD, FRCP(C), Juzar. Otolaryngologic Effects of Inhaled Medications Used in Pulmonary Medicine: A Review. Medical Research Archives, [S.l.], v. 14, n. 5, june 2026. ISSN 2375-1924. Available at: <https://esmed.org/MRA/mra/article/view/7505>. Date accessed: 02 june 2026.
ABNT APA BibTeX CBE EndNote - EndNote format (Macintosh & Windows) MLA ProCite - RIS format (Macintosh & Windows) RefWorks Reference Manager - RIS format (Windows only) Turabian
Keywords
Otolaryngologic effects, Pulmonary disease, Inhaled therapy, Aerosolized medication, Nebulization
Issue
Vol 14 No 5 (2026): Vol.14 Issue 5 May 2026
Section
Review Articles

The Medical Research Archives grants authors the right to publish and reproduce the unrevised contribution in whole or in part at any time and in any form for any scholarly non-commercial purpose with the condition that all publications of the contribution include a full citation to the journal as published by the Medical Research Archives.